Wellspect HealthCare Recognized as One of Europe’s Climate Leaders 2025
Mölndal, Sweden – July 02, 2025 – Wellspect HealthCare, a global provider of continence care solutions and a subsidiary of Dentsply Sirona, has been named one of Europe’s Climate Leaders 2025 by the Financial Times in collaboration with Statista1. The recognition highlights 600 companies across Europe that have achieved substantial reductions in greenhouse gas emissions relative to revenue, while maintaining transparency in their climate reporting.
Wellspect has strengthened its position on the list compared to last year -acknowledging the company’s continued progress in reducing emissions and advancing environmental accountability across its operations.
“This recognition reflects a clear direction for Wellspect - one where clinical performance and environmental responsibility go hand in hand,” said Chris Schlenk, Group Vice President, Wellspect HealthCare. “Sustainability is a commitment we embed in every part of our value chain - from how we produce our products to how we deliver them. Being named a European Climate Leader validates the hard work of our teams and partners.”
Wellspect has successfully reduced greenhouse gas emissions from both its own operations and the energy it consumes. In addition, the company’s short- and long-term emissions reduction targets - covering both direct and indirect emissions—have been validated by the Science Based Targets initiative (SBTi), a key factor in this year’s improved ranking.
Key areas of focus for the continued work include:
- Reducing emissions from chemicals used in production
- Lowering transport-related emissions
- Increasing energy efficiency and expanding the use of alternative energy sources
- Deepening collaboration with suppliers to strengthen climate action throughout the value chain
Wellspect aims to reach net-zero greenhouse gas emissions by 2045. This recognition reaffirms the company’s long-term ambition: to be a trusted leader in healthcare by delivering solutions that are both clinically effective and developed with a lower environmental impact.
[1] Europe’s Climate Leaders 2025: interactive listing
Read more here about Wellspect’s sustainability work.
Marion Par-Weixlberger | Vice President Public Relations & Corporate Communications
Sirona Straße 1 | 5071 Wals bei Salzburg | Austria
T +43 (0) 662 2450-588 | F +43 (0) 662 2450-540
marion.par-weixlberger@dentsplysirona.com | www.dentsplysirona.com
About Us
Wellspect HealthCare, a subsidiary of Dentsply Sirona, is a leading global provider of innovative medical devices dedicated to improving the quality of life for individuals with bladder and bowel dysfunction.
With approximately 1,200 employees worldwide, Wellspect is committed to making a real difference for people managing continence care needs, empowering them to live each day to the fullest.
Wellspect delivers solutions that support safe bladder and bowel management, and continuously enhances the user experience, clinical performance, and service quality for healthcare professionals and users alike.
As one of the world’s leading manufacturers of intermittent urinary catheters, Wellspect has been at the forefront of innovation since 1983 with its LoFric® brand, which introduced the first hydrophilic-coated catheter.
Wellspect has also pioneered the development of Navina™, an innovative transanal irrigation system designed to support individuals living with chronic bowel disorders.
Every day, Wellspect strives to maintain the highest quality standards while minimizing the environmental impact of its products.
Headquartered in Mölndal, Sweden, Wellspect operates in more than 40 countries, offering life-enhancing solutions to people around the world. Dentsply Sirona, the world’s largest diversified manufacturer of professional dental products and technologies, is listed on Nasdaq under the symbol XRAY.
Tags:
